MRI-guided prostate radiation with a targeted dose boost
Part of Cancer, Kidney & urinary clinical trials.
This study tests whether adding a stronger, focused radiation “boost” to a visible prostate spot—using real-time MRI guidance—can improve treatment for locally advanced prostate cancer. It may help better control the tumor while still delivering standard radiation to the rest of the prostate area.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man age 18 or older with prostate cancer confirmed by biopsy
- Your MRI shows stage T3b, with no nearby nodes (N0) and no spread to distant organs (M0)
- A specific prostate lesion (abnormal spot) is visible on MRI before treatment
- You can have a full MRI scan (you can lie still for about 45–60 minutes and don’t have severe claustrophobia)
- You have a pre-treatment PSMA PET/CT scan available
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a precise, MRI-guided radiation treatment given over 7 days for people with prostate cancer in specific risk categories. It may help shrink or control the cancer while carefully targeting the tumor.
This trial tests a new, shorter course of radiation for intermediate-risk prostate cancer. It aims to give a higher dose to the main tumor while keeping side effects low.
This trial tests a special type of radiation therapy (SBRT) that delivers a higher dose directly to the main tumor in your prostate, guided by a PSMA PET scan. It aims to improve cancer control while limiting side effects.
This study tests a new radiation treatment approach that uses MRI imaging to target specific tumor areas within the prostate while reducing radiation to healthy tissue. It may help patients with early-stage prostate cancer get effective treatment with fewer side effects.
This study tests a higher dose of radiation for prostate cancer using an MRI-guided machine (MR-Linac). It aims to see if a more targeted dose can be safely given to the tumor while protecting healthy tissue.
This trial tests a newer, more precise radiation treatment that gives a higher dose to the main tumor while keeping radiation to the rest of the prostate the same. It is for men with intermediate- or high-risk prostate cancer who haven't had prior prostate radiation or removal.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.